This is of particular interest considering the established risk of FSGS in African American patients harboring APOL1 risk alleles,1,3,35 and the faster rate of kidney disease progression observed among patients with CKD36 or FSGS37 with a high-risk compared to a low-risk APOL1 genotype. The gene discussed is APOL1; the disease is kidney disorder.